menu search

Sales of intravenous iron drugs market is estimated to hit us$ 6.3 bn at a cagr of 8.5% by year 2032-end | future market insights, inc.

Ferric Carboxymaltose to Generate nearly 50% of the intravenous Iron Drugs Market throughout the Analys...

December 8, 2022, 2:30 am

Provention bio gets fda approval for treatment that can delay onset of type 1 diabetes

Shares of Provention Bio Inc. PRVB, -1.09% were down 3.9% in trading on Friday morning, the day after the Food and Drug Administration approved the co...

November 18, 2022, 11:36 am

Victory square technologies subsidiary vs digital health launches the dripbar on apple and google app stores

Victory Square Technologies Inc (CSE:VST, OTCQX:VSQTF) has announced that its white labeled software technology platform from subsidiary VS Digital H...

August 9, 2022, 9:21 am

Braxia scientific expands canadian mental health clinic footprint with newest location in ontario's kitchener-waterloo region

Braxia Scientific Corp has announced the opening of its newest Braxia Health clinic in the Kitchener-Waterloo area in Ontario, its fifth locatio...

June 15, 2022, 9:20 am

Fda gives green signal to human trial for sorrento's sti-9167 against omicron

The FDA has cleared Sorrento Therapeutics Inc's (NASDAQ: SRNE) investigational new drug application (IND) for ...

April 25, 2022, 4:15 pm

Roche (rhhby) actemra application receives priority review

Roche (RHHBY) sBLA is seeking approval for the intravenous formulation of arthritis drug Actemra accept...

April 5, 2022, 1:33 pm

Capricor shares fall after topline results from mid-stage covid-19 trial

Capricor Therapeutics Inc (NASDAQ: CAPR) announced topline data from its Phase 2 INSPIRE study evaluating a single-dose ...

March 28, 2022, 12:22 pm

Argenx's subcutaneous efgartigimod at par with intravenous administration in neuromuscular disorder

Argenx SE (NASDAQ: ARGX) ) has announced topline data from the Phase 3 ADAPT-SC study evaluating subcutaneous (SC) efgartigimod for generalized mya...

March 22, 2022, 12:30 pm

Biogen to present new research at the international conference on alzheimer's and parkinson's diseases (ad/pd 2022)

CAMBRIDGE, Mass., March 11, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the company will present new Alzheimer's disease research, ...

March 11, 2022, 4:30 pm

Wellbeing digital sciences delivers first iv ketamine treatment under new in-patient program

Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc, formerly known as Ketamine One, has announced the successful facilitation of its first ...

February 15, 2022, 7:36 am

Wellbeing digital sciences delivers first iv ketamine treatment under new in-patient program

Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc, formerly known as Ketamine One, has announced the successful facilitation of its first ...

February 15, 2022, 7:36 am

Wellbeing digital sciences delivers first iv ketamine treatment under new in-patient program

Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc, formerly known as Ketamine One, has announced the successful facilitation of its first ...

February 15, 2022, 7:36 am


Search within

Pages Search Results: